BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 5 April, 2007
Biotie Therapies Corp. (the "Company") has gained knowledge of the
following notification under Chapter 2, Section 9 of the Finnish
Securities Market Act regarding a change in holdings on 30 March
2007:
The aggregate holding of Pequot Healthcare Fund, L.P., Pequot
Healthcare Offshore Fund, Inc., Premium Series PCC Limited - Cell 32,
Pequot Diversified Master Fund, Ltd., Pequot Healthcare Institutional
Fund, L.P. and Pequot Healthcare Emerging Markets Fund, Ltd.
(jointly, the "Funds") have increased from 23.16 % to 25.76 % of the
share capital and voting rights of the Company, calculated on the
basis of the number of shares registered in the Finnish Trade
Register on 4 April 2007. No individual Fund has decreased its
holding below or above 5 % of the voting rights and share capital in
the Company.
Under Chapter 2, Section 9 of the Securities Market Act regarding a
change in holdings the Funds aggregated holding has exceeded 25 % of
the voting rights in and number of shares of the Company as follows:
+-------------------------------------------------------------------+
| Shareholder | Number of shares | Proportion of |
| | | share capital and |
| | | voting rights |
|----------------------------+------------------+-------------------|
| Pequot Healthcare Fund, | 8,330,596 | 9.28 % |
| L.P. | | |
|----------------------------+------------------+-------------------|
| Pequot Healthcare Offshore | 6,397,683 | 7.12 % |
| Fund, Inc. | | |
|----------------------------+------------------+-------------------|
| Premium Series PCC Limited | 998,490 | 1.11 % |
| - Cell 32 | | |
|----------------------------+------------------+-------------------|
| Pequot Diversified Master | 1,201,800 | 1.34 % |
| Fund, Ltd | | |
|----------------------------+------------------+-------------------|
| Pequot Healthcare | 1,704,406 | 1.90 % |
| Institutional Fund, L.P | | |
|----------------------------+------------------+-------------------|
| Pequot Healthcare Emerging | 4.500.000 | 5.01 % |
| Markets Master Fund, Ltd | | |
+-------------------------------------------------------------------+
The share capital of Biotie Therapies Corp. constitutes 89,800,660
shares in the aggregate and the number of voting rights attached to
the shares amounts to 89,800,660.
Turku, on 5 April, 2007
Timo Veromaa
President and CEO
For further information, please contact:
Timo Veromaa, President and CEO, Biotie Therapies Corp.
tel. +358 2 274 8954, e-mail: timo.veromaa@biotie.com
www.biotie.com
DISTRIBUTION The Helsinki Stock Exchange
Main Media
NOTIFICATION UNDER CHAPTER 2, SECTION 10 OF THE FINNISH SECURITIES MARKET ACT REGARDING CHANGE IN HOLDINGS
| Source: Biotie Therapies